Hepatitis E Virus and Chronic Hepatitis in Organ-Transplant Recipients, New England Journal of Medicine, vol.358, issue.8, pp.811-817, 2008. ,
DOI : 10.1056/NEJMoa0706992
URL : https://hal.archives-ouvertes.fr/inserm-00409083
Chronic Hepatitis E with Cirrhosis in a Kidney-Transplant Recipient, New England Journal of Medicine, vol.358, issue.8, pp.859-860, 2008. ,
DOI : 10.1056/NEJMc0708687
Hepatitis E Virus-Related Cirrhosis in Kidney-and Kidney-Pancreas-Transplant Recipients, American Journal of Transplantation, vol.356, issue.8, pp.1744-1748, 2008. ,
DOI : 10.1111/j.1600-6143.2008.02286.x
URL : https://hal.archives-ouvertes.fr/inserm-00409074
Hepatitis E Virus and Neurologic Disorders, Emerging Infectious Diseases, vol.17, issue.2, pp.173-179, 2011. ,
DOI : 10.3201/eid1702.100856
Review of neurological manifestations of hepatitis E infection, Ann Hepatol, vol.11, issue.5, pp.618-622, 2012. ,
Hepatitis E Virus and the Kidney in Solid-Organ Transplant Patients, Transplantation, vol.93, issue.6, pp.617-623, 2012. ,
DOI : 10.1097/TP.0b013e318245f14c
membranous nephropathy (MN) in kidney allografts. A peculiar form of alloimmune disease?, Transplant International, vol.23, issue.Suppl. 1, pp.1205-1210, 2012. ,
DOI : 10.1111/j.1432-2277.2012.01548.x
Receptor as Target Antigen in Idiopathic Membranous Nephropathy, New England Journal of Medicine, vol.361, issue.1, pp.11-21, 2009. ,
DOI : 10.1056/NEJMoa0810457
URL : https://hal.archives-ouvertes.fr/hal-00417718
Autoantibodies Specific for the Phospholipase A2 Receptor in Recurrent and???De Novo???Membranous Nephropathy, American Journal of Transplantation, vol.79, issue.suppl, pp.2144-2152, 2011. ,
DOI : 10.1111/j.1600-6143.2011.03643.x
URL : https://hal.archives-ouvertes.fr/inserm-00919176
Pathogenesis of membranous nephropathy: recent advances and future challenges, Nature Reviews Nephrology, vol.181, issue.4, pp.203-213, 2012. ,
DOI : 10.1007/s00467-006-0203-6
URL : https://hal.archives-ouvertes.fr/inserm-00919135
Pathogenesis, diagnosis and management of paraneoplastic glomerulonephritis, Nature Reviews Nephrology, vol.53, issue.2, pp.85-95, 2011. ,
DOI : 10.1038/nrneph.2010.171
Management of Side Effects of Sirolimus Therapy, Transplantation, vol.87, issue.Supplement, pp.23-26, 2009. ,
DOI : 10.1097/TP.0b013e3181a05b7a
High Sirolimus Levels May Induce Focal Segmental Glomerulosclerosis De Novo, Clinical Journal of the American Society of Nephrology, vol.2, issue.2, pp.326-333, 2007. ,
DOI : 10.2215/CJN.03751106
Rapamycin-associated post-transplantation glomerulonephritis and its remission after reintroduction of calcineurin-inhibitor therapy, Transplant International, vol.14, issue.4, pp.215-220, 2004. ,
DOI : 10.1097/00002281-200209000-00006
Deposition of hepatitis B e antigen in membranous glomerulonephritis: Identification by F(ab???)2 fragments of monoclonal antibody, Kidney International, vol.26, issue.3, pp.338-341, 1984. ,
DOI : 10.1038/ki.1984.178
Hepatitis B infection and renal disease: Clinical, immunopathogenetic and therapeutic considerations, Kidney International, vol.37, issue.2, pp.663-676, 1990. ,
DOI : 10.1038/ki.1990.32
Sustained virologic response with ribavirin in chronic hepatitis E virus infection in heart transplantation, The Journal of Heart and Lung Transplantation, vol.30, issue.7, pp.841-843, 2011. ,
DOI : 10.1016/j.healun.2011.03.013
Ribavirin Therapy Inhibits Viral Replication on Patients With Chronic Hepatitis E Virus Infection, Gastroenterology, vol.139, issue.5, pp.1612-1618, 2010. ,
DOI : 10.1053/j.gastro.2010.08.002
Brief Communication: Case Reports of Ribavirin Treatment for Chronic Hepatitis E, Annals of Internal Medicine, vol.153, issue.2, pp.85-89, 2010. ,
DOI : 10.7326/0003-4819-153-2-201007200-00257